神经科

订阅

MedSci主页 / 所有栏目 / 神经科

青年卒中与PFO的相关性分析

2022-08-27 韩翔 MedSci原创

神经科神经外科
关注

复旦大学附属华山医院

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1924762, encodeId=1a981924e629c, content=<a href='/topic/show?id=f9dc1412453' target=_blank style='color:#2F92EE;'>#PFO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14124, encryptionId=f9dc1412453, topicName=PFO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Fri Jan 20 06:15:13 CST 2023, time=2023-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1838103, encodeId=fca51838103a3, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Sep 21 20:15:13 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770059, encodeId=a72e1e70059d5, content=<a href='/topic/show?id=57d2990006f' target=_blank style='color:#2F92EE;'>#青年卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99000, encryptionId=57d2990006f, topicName=青年卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=749838134979, createdName=李研东, createdTime=Sat Feb 04 02:15:13 CST 2023, time=2023-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523672, encodeId=db0715236e2fe, content=<a href='/topic/show?id=f6f1e2533e3' target=_blank style='color:#2F92EE;'>#相关性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72533, encryptionId=f6f1e2533e3, topicName=相关性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad8f11536374, createdName=anminleiryan, createdTime=Thu Aug 25 04:15:13 CST 2022, time=2022-08-25, status=1, ipAttribution=)]
    2023-01-20 Boyinsh

    #PFO#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1924762, encodeId=1a981924e629c, content=<a href='/topic/show?id=f9dc1412453' target=_blank style='color:#2F92EE;'>#PFO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14124, encryptionId=f9dc1412453, topicName=PFO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Fri Jan 20 06:15:13 CST 2023, time=2023-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1838103, encodeId=fca51838103a3, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Sep 21 20:15:13 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770059, encodeId=a72e1e70059d5, content=<a href='/topic/show?id=57d2990006f' target=_blank style='color:#2F92EE;'>#青年卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99000, encryptionId=57d2990006f, topicName=青年卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=749838134979, createdName=李研东, createdTime=Sat Feb 04 02:15:13 CST 2023, time=2023-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523672, encodeId=db0715236e2fe, content=<a href='/topic/show?id=f6f1e2533e3' target=_blank style='color:#2F92EE;'>#相关性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72533, encryptionId=f6f1e2533e3, topicName=相关性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad8f11536374, createdName=anminleiryan, createdTime=Thu Aug 25 04:15:13 CST 2022, time=2022-08-25, status=1, ipAttribution=)]
    2022-09-21 shenxlcyp

    #相关性#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1924762, encodeId=1a981924e629c, content=<a href='/topic/show?id=f9dc1412453' target=_blank style='color:#2F92EE;'>#PFO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14124, encryptionId=f9dc1412453, topicName=PFO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Fri Jan 20 06:15:13 CST 2023, time=2023-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1838103, encodeId=fca51838103a3, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Sep 21 20:15:13 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770059, encodeId=a72e1e70059d5, content=<a href='/topic/show?id=57d2990006f' target=_blank style='color:#2F92EE;'>#青年卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99000, encryptionId=57d2990006f, topicName=青年卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=749838134979, createdName=李研东, createdTime=Sat Feb 04 02:15:13 CST 2023, time=2023-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523672, encodeId=db0715236e2fe, content=<a href='/topic/show?id=f6f1e2533e3' target=_blank style='color:#2F92EE;'>#相关性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72533, encryptionId=f6f1e2533e3, topicName=相关性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad8f11536374, createdName=anminleiryan, createdTime=Thu Aug 25 04:15:13 CST 2022, time=2022-08-25, status=1, ipAttribution=)]
    2023-02-04 李研东

    #青年卒中#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1924762, encodeId=1a981924e629c, content=<a href='/topic/show?id=f9dc1412453' target=_blank style='color:#2F92EE;'>#PFO#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14124, encryptionId=f9dc1412453, topicName=PFO)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=726030, createdName=Boyinsh, createdTime=Fri Jan 20 06:15:13 CST 2023, time=2023-01-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1838103, encodeId=fca51838103a3, content=<a href='/topic/show?id=3f34e253206' target=_blank style='color:#2F92EE;'>#相关性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72532, encryptionId=3f34e253206, topicName=相关性)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a9de34, createdName=shenxlcyp, createdTime=Wed Sep 21 20:15:13 CST 2022, time=2022-09-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1770059, encodeId=a72e1e70059d5, content=<a href='/topic/show?id=57d2990006f' target=_blank style='color:#2F92EE;'>#青年卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=99000, encryptionId=57d2990006f, topicName=青年卒中)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=749838134979, createdName=李研东, createdTime=Sat Feb 04 02:15:13 CST 2023, time=2023-02-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1523672, encodeId=db0715236e2fe, content=<a href='/topic/show?id=f6f1e2533e3' target=_blank style='color:#2F92EE;'>#相关性分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=72533, encryptionId=f6f1e2533e3, topicName=相关性分析)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ad8f11536374, createdName=anminleiryan, createdTime=Thu Aug 25 04:15:13 CST 2022, time=2022-08-25, status=1, ipAttribution=)]
    2022-08-25 anminleiryan

    #相关性分析#

    0

相关资讯

四川大学华西医院：痴呆及阿尔茨海默病进展要点简析

四川大学华西医院对痴呆及阿尔茨海默病的研究进展进行综述，旨在提升大众对痴呆的总体认识。

即将直播：取栓失败的补救措施和策略

北京天坛医院宋立刚教授带您掌握取栓失败后的紧急补救策略！

即将直播：神经科医生如何读懂肌电图

中国医科大学附属盛京医院

今晚直播：中枢神经系统单发/多发病变的诊断思路和实践

复旦大学附属华山医院

今晚直播：震颤的诊断思路有哪些？

首都医科大学附属北京天坛医院神经病学中心

痴呆及阿尔茨海默病进展要点简析

本文对痴呆及阿尔茨海默病的研究进展进行综述，旨在提升大众对痴呆的总体认识。